本研究分别对240名缺血性中风患者和105名该领域专家采取调查问卷形式开展缺血性中风病的中药临床试验的伦理研究调查，并对该调查结果进行了分析，旨在规范对缺血性中风病中药临床试验的伦理审查，更好地保护受试者的权益。

This article was based on the investigation of ethical research in traditional Chinese medicine (TCM) clinical trials among 240 ischemic stroke patients and 105 experts specialized in this field. Analysis was given on the research results. This article was intended to regulate the ethical review of ischemic stroke, and to protect the rights and interests of the subjects better.

科学技术部国家科技重大专项（2011ZX09302-006-01-01）：中药新药临床评价研究技术平台，负责人：田金洲。